REVENTIVE CARE - AN OVERVIEW

DetailsClick HereIn light of remarks on the OTC Preventive Solutions RFI, ongoing issues to the Departments and credible stories of widespread failure by plans and issuers to provide coverage of the complete variety of contraceptive expert services, and new Executive Orders, as well as FDA approval in July 2023 of a progestin-only oral contraceptiv